Pharmaceuticals, Biotechnology and Life Sciences
BOSTON & GHENT, Belgium–(BUSINESS WIRE)–Orionis Biosciences is today debuting with the announcement of a major drug discovery collaboration with Novartis.…
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today…
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative…
Partners with Trammell Crow Company to provide start-up lab space CHICAGO–(BUSINESS WIRE)–Portal Innovations, LLC today announced they are launching a…
IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) today announced that the U.S. Food and Drug Administration (FDA) has…
Initiated Phase 1 Clinical Trial of SY-5609 in Select Solid Tumors Patients Entered into Collaboration with GBT to Advance Novel…
—Construction of R&D and cGMP Manufacturing Facility Underway in New Jersey— —Preliminary Clinical Data of RP-L102 in FA and RP-L201…
MILAN–(BUSINESS WIRE)–$NWRN #RareDisease–Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies…
Interim analysis data is expected Q4 2020 Can Fite possesses US patent protecting the anti-viral effects of its two drug…
OXFORD, England–(BUSINESS WIRE)–PsiOxus® Therapeutics, Ltd. (PsiOxus), the gene therapy for cancer company, today announced that it has started a clinical…